The HMGB1-TLR4/NF-κB signalling pathway found its way in the development of ALI/ARDS; inhibiting the overexpression and release of HMGB1 is believed to be an effective approach to ALI/ARDS treatment [6, 12]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.